Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
Back
CAS
941678-49-5
Purity
95%
Ruxolitinib is an antineoplastic agent that inhibits cell proliferation, induces apoptosis of malignant cells, and reduces pro-inflammatory cytokine plasma levels by inhibiting JAK-induced phosphorylation of signal transducer and activator of transcription (STAT). It is used to treat various types of myelofibrosis, polycythemia vera.
Properties
Name
Ruxolitinib
Smiles
N#CC[C@H](C1CCCC1)N2C=C(C=N2)C=3N=CN=C4NC=CC34
Targets
Please log in to see this information
(R)-ruxolitinib | INCB018424 | Rux | jakafi | ruxolitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$47
2 mg
$49
5 mg
$50
10 mg
$51
15 mg
$52
20 mg
$53
25 mg
$59
30 mg
$65
35 mg
$73
40 mg
$80
45 mg
$87
50 mg
$94
75 mg
$100
100 mg
Get a quoteQuantity
1
Total amount
$ 50
(R)-ruxolitinib | INCB018424 | Rux | jakafi | ruxolitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
Powered by Bioz